Effect of polyanion-resistance on HIV-1 infection

被引:19
作者
Bobardt, MD
Armand-Ugón, M
Clotet, I
Zhang, Z
David, G
Este, JA
Gallay, PA
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Hosp Germans Trias & Pujol, Retrovirol Lab IrsiCaixa, Badalona 08916, Spain
[3] Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
[4] Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium
关键词
polyanion; HIV-1; T cell;
D O I
10.1016/j.virol.2004.05.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Polyanions are potent HIV-1 entry inhibitors. Nevertheless, resistant viruses may emerge under polyanion inhibitory pressure. Specifically.. a polyanion-resistant virus replicates in T cells even in the presence of high concentrations of polyanions. We found that although the polyanion-resistant virus grows in suspension CD4+ T cells efficiently, it infects nonlymphocytic adherent CD4+ cells poorly. Given that a main distinction between suspension and adherent cells is the absence or presence of cell-surface heparan sulfate proteoglycan (HSPG), we investigated if the failure of the polyanion-resistant virus to infect adherent CD4+ cells arises from its inability to bind HSPG. We found that the emergence of mutations in gp120 associated with polyanion resistance resulted in a decreased capacity of HIV-1 to bind HSPG. We also found that the polycation polybrene rescued the capacity of the polyanion-resistant virus to bind HSPG and to infect adherent CD4+ cells. The identification of this virus, unable to bind HSPG, provides a convenient probe to measure the impact of HIV-1-HSPG interactions in vivo. Altogether, these findings suggest that polyanion-resistance narrows the range of potential target cells for HIV-1 in the host. This reinforces the hypothesis that cell-free or cell-associated polyanions such as HSPG possess the capacity to modulate HIV-1 pathogenesis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 41 条
  • [1] Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts
    Argyris, EG
    Acheampong, E
    Nunnari, G
    Mukhtar, M
    Williams, KJ
    Pomerantz, RJ
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (22) : 12140 - 12151
  • [2] SULFATED POLYSACCHARIDES ARE POTENT AND SELECTIVE INHIBITORS OF VARIOUS ENVELOPED VIRUSES, INCLUDING HERPES-SIMPLEX VIRUS, CYTOMEGALO-VIRUS, VESICULAR STOMATITIS-VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS
    BABA, M
    SNOECK, R
    PAUWELS, R
    DECLERCQ, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) : 1742 - 1745
  • [3] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF SULFATED MONOSACCHARIDES - COMPARISON WITH SULFATED POLYSACCHARIDES AND OTHER POLYIONS
    BAGASRA, O
    WHITTLE, P
    HEINS, B
    POMERANTZ, RJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) : 1082 - 1090
  • [4] Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding
    Basmaciogullari, S
    Babcock, GJ
    Van Ryk, D
    Wojtowicz, W
    Sodroski, J
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (21) : 10791 - 10800
  • [5] Functions of cell surface heparan sulfate proteoglycans
    Bernfield, M
    Götte, M
    Park, PW
    Reizes, O
    Fitzgerald, ML
    Lincecum, J
    Zako, M
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 : 729 - 777
  • [6] Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion
    Bobardt, MD
    Salmon, P
    Wang, LC
    Esko, JD
    Gabuzda, D
    Fiala, M
    Trono, D
    Van der Schueren, B
    David, G
    Gallay, PA
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (12) : 6567 - 6584
  • [7] Syndecan captures, protects, and transmits HIV to T lymphocytes
    Bobardt, MD
    Saphire, ACS
    Hung, HC
    Yu, XC
    Van der Schueren, B
    Zhang, Z
    David, G
    Gallay, PA
    [J]. IMMUNITY, 2003, 18 (01) : 27 - 39
  • [8] DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS
    CALLAHAN, LN
    PHELAN, M
    MALLINSON, M
    NORCROSS, MA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (03) : 1543 - 1550
  • [9] Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor
    Derdeyn, CA
    Decker, JM
    Sfakianos, JN
    Zhang, ZJ
    O'Brien, WA
    Ratner, L
    Shaw, GM
    Hunter, E
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (18) : 8605 - 8614
  • [10] The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication
    DeVreese, K
    KoflerMongold, V
    Leutgeb, C
    Weber, V
    Vermeire, K
    Schacht, S
    Anne, J
    DeClercq, E
    Datema, R
    Werner, G
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 689 - 696